Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Prostate Cancer and Prostatic Diseases|October 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancerPornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai, et al.
JCO Oncology Practice|February 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing TestingMadelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh, et al.
NPJ Genomic Medicine|January 22, 2024
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancerHannah E Bergom, Laura A Sena, Abderrahman Day, et al.
JCO Oncology Practice|September 27, 2021
Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With CancerLaura A Sena, Ramy Sedhom, Susan Scott, et al.
Science (New York, N.Y.)|September 21, 2013
Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in miceClara Bien Peek, Alison H Affinati, Kathryn Moynihan Ramsey, et al.
Nature Communications|January 3, 2024
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trialMark C Markowski, Mary-Ellen Taplin, Rahul Aggarwal, et al.
The Oncologist|November 20, 2020
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate CancerLaura A Sena, Julia Fountain, Pedro Isaacsson Velho, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancerRajendra Kumar, Sheila Jonnatan, David E Sanin, et al.
The Journal of Clinical Investigation|October 4, 2022
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYCLaura A Sena, Rajendra Kumar, David E Sanin, et al.
Pageof 4